China
Africa
Explore chapters and articles related to this topic
Sweat Rate Wearable Sensors
Published in Krzysztof Iniewski, Biological and Medical Sensor Technologies, 2017
Common therapies are based on diets and pharmacotherapy that are specific for each patient, but which have side effects and may only have a short period of applicability. Another option is bariatric surgery mainly based on reducing stomach size. In general, weight reduction can be accomplished, but there are operative risks including mortality. The best solution is prevention by constantly monitoring the evolution of obesity over time. This is extremely important when children are obese since it is very probable they will be obese as adults. As with sports applications, a wearable sensor can help not only the patient but also the doctor to keep under control the patient’s health status by means of an indirect analysis from sweat production.
How viable is pre-surgery weight reduction for the reduction of periprosthetic joint infection risk after total joint arthroplasty?
Published in Expert Review of Medical Devices, 2020
Michael Yayac, Rajesh Aggarwal, Javad Parvizi
For some patients, especially those with a BMI of 40 or greater, bariatric surgery may be the only feasible option to achieve and sustain substantial weight loss. In recent years, there have been three commonly performed procedures, including laparoscopic Roux-en-Y gastric bypass (RYGB), laparoscopic sleeve gastrectomy, and laparoscopic gastric banding [7]. While still performed, laparoscopic gastric banding has fallen out of favor as a surgical option due to inferior outcomes and complications secondary to band slippage, erosions, and viscous penetrations, necessitating removal [8]. RYGB is considered the gold-standard procedure, having demonstrated superior results through several studies with long-term follow-up [9]. However, sleeve gastrectomy has recently become the preferred procedure for many bariatric surgeons due to its relative technical ease and lower risk of complications [7,8]. Evidence regarding the long-term outcomes of sleeve gastrectomy is limited, but two recent RCTs comparing sleeve gastrectomy to RYGB found no clinically significant differences between the procedures at a 5-year follow-up [7,10]. Unlike lifestyle modification or weight loss medications, bariatric surgery can result in rapid weight loss, which may be substantial enough to impact the risk of PJI. Patients undergoing either RYGB or sleeve gastrectomy have achieved BMI reductions of 11.5 to 13.1 points within 1 year, losing greater than 70% of their excess weight, and the success of these of procedures has been linked to numerous health benefits including improved glucose tolerance, blood pressure control, and blood lipid levels [7,9,10].
Systematic review on gastric electrical stimulation in obesity treatment
Published in Expert Review of Medical Devices, 2019
Alimujiang Maisiyiti, Jiande Dz Chen
Surgical treatment is typically recommended for adults with a BMI ≥40 kg/m2 without comorbid illness, or a BMI of 35 to 39.9 kg/m2 with at least one serious comorbidity, who have not met weight loss goals with diet, exercise, and drug therapy [8]. Several surgical procedures are being used clinically, the most common bariatric surgery procedures are gastric bypass, sleeve gastrectomy and biliopancreatic diversion with duodenal switch [9]. Among these various procedures, sleeve gastrectomy is a more commonly performed bariatric procedure for obesity without diabetes, whereas Roux-en-Y gastric bypass has a reliable hypoglycemic effect in addition to weight loss. A recent IFSO worldwide surgery in 2016 reported that the total number of bariatric/metabolic procedures in 2016 was 685, 874 and the most performed procedures were sleeve gastrectomy (53.6%) followed by Roux-en-Y gastric bypass (30.1%) and one-anastomosis gastric bypass (4.8%) [10].
Effect of a randomised 12-week resistance training programme on muscular strength, cross-sectional area and muscle quality in women having undergone Roux-en-Y gastric bypass
Published in Journal of Sports Sciences, 2018
Paul Daniels, Ryan D. Burns, Timothy A. Brusseau, Morgan S. Hall, Lance Davidson, Ted D. Adams, Patricia Eisenman
The positive clinical and health outcomes related to bariatric surgery have been well documented, including loss of excess body weight and improvements in obesity-related co-morbid conditions such as insulin resistance, type 2 diabetes and dyslipidemia (Adams et al., 2012; Buchwald, 2002; Christou et al., 2004). Despite the positive health benefits from surgical weight loss, one negative outcome appears to be a significant loss of fat-free mass (FFM) and skeletal muscle mass (Chaston, Dixon, & O’Brien, 2007; Levitt et al., 2010; Lyytinen, Liikavainio, Paakkonen, Gylling, & Arokoski, 2013). The loss of FFM and skeletal muscle mass, both considered lean tissues, may have serious negative implications for mobility, weight regain and physical function, especially as one ages (Heymsfield, Gonzalez, Shen, Redman, & Thomas, 2015).